Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Concord Biotech Ltd.
Swot
Concord Biotech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Concord Biotech Ltd. has 10 Strengths, 11 Weaknesses, 0 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(10)
Weakness
(11)
Opportunity
(0)
Threats
(1)
Others
(5)
Benjamin Graham Value Screen
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Expensive Performers (DVM)
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Negative Breakdown First Support (LTP < S1)
PEG greater than Industry PEG
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Declining Net Cash Flow : Companies not able to generate net cash
Fall in Quarterly Revenue and Net Profit (YoY)
Weak Momentum: Price below Short, Medium and Long Term Averages
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Increasing Trend in Non-Core Income
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
MFs decreased their shareholding last quarter
Rising Delivery Percentage Compared to Prev Day
Expensive Performers (DVM)
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)
